Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,139 | 91,681 | 105,730 | 76,418 | 36,294 |
| Receivables | 57,446 | 24,855 | 18,817 | 44,200 | 3,293 |
| Inventories | 13,521 | 18,325 | 16,897 | 24,721 | 16,441 |
| Income taxes - deferred | 1,870 | N/A | N/A | 295 | 1,989 |
| Other current assets | 10,000 | 10,000 | 0 | 0 | 0 |
| TOTAL | $193,814 | $152,887 | $144,310 | $147,337 | $59,116 |
| Non-Current Assets | |||||
| PPE Net | 131,834 | 124,656 | 110,218 | 78,174 | 30,645 |
| Other Non-Current Assets | 19,041 | 13,245 | 18,980 | 12,744 | 10,571 |
| TOTAL | $150,875 | $137,901 | $129,198 | $90,918 | $41,216 |
| Total Assets | $344,689 | $290,788 | $273,508 | $238,255 | $100,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,791 | 6,248 | 3,514 | 2,456 | 902 |
| Accounts payable and accrued liabilities | 17,159 | 18,254 | 20,257 | 27,366 | 10,425 |
| Accrued Expenses | 16,496 | 12,779 | 11,280 | 10,460 | 8,786 |
| TOTAL | $54,701 | $54,021 | $55,661 | $64,347 | $30,093 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44,927 | 35,935 | 42,588 | 31,368 | 10,502 |
| Deferred Revenues | 255 | 232 | 902 | 1,432 | 7,340 |
| Other Non-Current Liabilities | 5,845 | 2,207 | 1,627 | 1,071 | 0 |
| TOTAL | $46,173 | $37,418 | $46,688 | $35,436 | $10,502 |
| Total Liabilities | $100,874 | $91,439 | $102,349 | $99,783 | $40,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,859 | 30,172 | 29,750 | N/A | N/A |
| Common Shares | 31 | 30 | 30 | 28 | 22 |
| Retained earnings | 122,152 | 91,008 | 70,326 | 47,997 | 25,396 |
| Other shareholders' equity | 1,140 | -859 | -1,130 | -473 | -276 |
| TOTAL | $243,815 | $199,349 | $171,159 | $138,472 | $59,737 |
| Total Liabilities And Equity | $344,689 | $290,788 | $273,508 | $238,255 | $100,332 |